A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Longterm Antithrombotic Therapy in Acute Coronary Syndrome Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 78,000
- 试验地点
- 1
- 主要终点
- number of patients with adverse events in patient groups with different antithrombotic treatment strategies
研究概览
简要总结
This observational study will based on the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA) and the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) which since 2009 are merged into The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART).
The aim of this study is to investigate the impact of different antithrombotic treatment options (treatment duration, type of treatment and combination of treatments) in Acute Coronary Syndrome (ACS) patients on outcomes such as recurrent ischemic events and mortality.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with an event of ACS under the study period
- •Patient found in the National Registry of Drug Prescriptions and treated or not treated with antithrombotic drug/s (acetylsalicylic acid and/or either clopidogrel/ticlopidine/prasugrel and/or warfarin)
排除标准
- •Patients will not be excluded from the database if they fulfill inclusion criteria.
结局指标
主要结局
number of patients with adverse events in patient groups with different antithrombotic treatment strategies
时间窗: up to 5 years and 6 months
adverse events such as: mortality, re-infarction, revascularization, ischemic- and non-ischemic stroke and bleeding
次要结局
未报告次要终点